ICGT ICG Enterprise Trust

ICG Enterprise Trust Plc: Notification of Share Transaction

ICG Enterprise Trust Plc: Notification of Share Transaction

ICG Enterprise Trust plc (the “Company”)

29 June 2023

Notification of Share Transaction

The Company has received notification that on 28 June 2023, David Warnock, a Non-Executive Director of the Company, bought a total of 10,000 ordinary shares in the Company at a price of 1075 pence per share.

As a result of these transactions David Warnock and his connected persons hold a total of 30,000 ordinary shares, being 0.044% of the ordinary share capital of the Company (excluding treasury shares).

Analyst / Investor enquiries:

Chris Hunt

Shareholder Relations, ICG

+44 (0) 20 3545 2020

Andrew Lewis

Company Secretary, ICG

+44 (0) 20 3545 1344

Media:



Clare Glynn,

Corporate Communications, ICG

+44 (0) 20 3545 1395



EN
29/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICG Enterprise Trust

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 20 June 2025 Transaction in Own Shares The Company announces that on 19 June 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1380 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 380,721.Total shares in issue excluding treasury shares following settlement of this purchase: 63,173,471. The Company has bought back these shares under the authority granted by shareholders at its Annual Gene...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 17 June 2025 Transaction in Own Shares The Company announces that on 16 June 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1370 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 365,721.Total shares in issue excluding treasury shares following settlement of this purchase: 63,188,471. The Company has bought back these shares under the authority granted by shareholders at its Annual Gene...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares CG Enterprise Trust plc (the “Company”)  16 June 2025  Transaction in Own Shares  The Company announces that on 13 June 2025 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1387 pence per share.  Further details are set out below:  Number of shares held as treasury shares following settlement of this purchase: 350,721.  Total shares in issue excluding treasury shares following settlement of this purchase: 63,203,471.  The Company has bought back these shares under the authority granted by shareholders at its...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 13 June 2025 Transaction in Own Shares The Company announces that on 12 June 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1402 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 340,721.Total shares in issue excluding treasury shares following settlement of this purchase: 63,213,471. The Company has bought back these shares under the authority granted by shareholders at its Annual Gene...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 12 June 2025 Transaction in Own Shares The Company announces that on 11 June 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1380 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 325,721.Total shares in issue excluding treasury shares following settlement of this purchase: 63,228,471. The Company has bought back these shares under the authority granted by shareholders at its Annual Gene...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch